The Pharmaletter

One To Watch

Sandoz

Sandoz is the generic pharma division of Novartis.

Sandoz is the generic pharma division of Novartis.

Want to Update your Company's Profile?

Latest Sandoz News

EC approval for Sandoz’s Afqlir

15 November 2024

Sandoz reports strong third-quarter 2024 sales

30 October 2024

Sandoz launches first FDA-approved generic of Abraxane

11 October 2024

Latest batch of EMA’s human medicines committee recommendations

20 September 2024

More Sandoz news >

Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze